Vivek Sharma is Chief Executive Officer, Piramal Pharma Solutions. Prior to this, he was Managing Director at THL Partners, a Boston based PE firm where he was responsible for working with THL's Portfolio companies to identify value creation opportunities and partner with the company's leadership team for execution of growth/restructuring and cost optimization initiatives. Vivek has over 20 years of Global Management experience and is a Chartered Accountant from India, a qualified CPA and also has a Masters in International Business from Thunderbird.
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policy makers.